Paper Details

  1. Home
  2. Paper Details

Twice daily 4% Sodium Cromoglycate vs. 2% Sodium Cromoglycate used four times daily in seasonal (grass pollen) allergic conjunctivitis.

Author: CollumA, CollumL M, FitzsimonS, HilleryM, JensonJ B, PelikanZ, PowerW J

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study compared the efficacy of 4% Sodium Cromoglycate used twice daily with 2% Sodium Cromoglycate used four times daily for treating seasonal allergic conjunctivitis. The results showed that 4% Sodium Cromoglycate was at least as effective as the 2% solution, suggesting that a twice-daily dosage may be sufficient.
Paper Details　
Original Abstract of the Article :
It is well established that 2% Sodium Cromoglycate is an effective treatment for a number of allergic eye diseases. It has been shown to be non-toxic. It can be used longterm and in serious allergic problems it is a useful adjunctive therapy to steroids. The main problem with Sodium Cromoglycate is ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/BF00160774

データ提供：米国国立医学図書館（NLM）

A Simpler Way to Treat Allergic Conjunctivitis?

The world of allergic conjunctivitis, or itchy, watery eyes, can be a real desert! This research delves into the effectiveness of different dosages of sodium cromoglycate, a common treatment for this condition. The researchers compared a 4% solution used twice daily with a 2% solution used four times daily. They used a multicenter study, which means they gathered data from different locations, to get a comprehensive picture of the results. They discovered that the 4% solution used twice daily was just as effective as the 2% solution used four times daily.

Double the Strength, Half the Trouble

The study suggests that a higher concentration of sodium cromoglycate could make treatment more convenient for patients. This could mean fewer drops to remember, leading to better adherence to the treatment plan. This finding is like finding a refreshing oasis in a vast desert – it makes treatment more manageable! The researchers found no significant side effects, making this a promising solution for people struggling with allergic conjunctivitis.

Keep Your Eyes on the Prize

The results of this research are good news for anyone with itchy, watery eyes. A more convenient treatment option could mean less discomfort and a better quality of life. This research provides a clear path to a more effective and less troublesome way to manage allergic conjunctivitis. So, if you suffer from this condition, talk to your doctor about the possibility of using a higher concentration of sodium cromoglycate.

Dr.Camel's Conclusion

The study offers a welcome solution for those who find it difficult to stick to a strict eye drop regimen. It's like finding a shortcut through the desert - a more convenient path to relief! This research opens up new possibilities for treating allergic conjunctivitis and improving the lives of those who suffer from this condition. Hopefully, the future holds even more advancements in treatment for allergic conjunctivitis, making the journey through the desert of itchy eyes a little less bumpy.

Date :
  1. Date Completed 1993-06-30
  2. Date Revised 2019-09-02
Further Info :

Pubmed ID

1303863

DOI: Digital Object Identifier

10.1007/BF00160774

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.